About: C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2001 (uk) im November 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2001 (ast) scientific article published on 01 November 2001 (en)
publication date	wds:Q61757263-4434A212-3792-4D4C-B47C-A72F317B98CC
publication date	2001-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61757263-86DCA880-929B-48B5-B0E2-630F3AD3DC3A
language of work or name	English
author name string	wds:Q61757263-21B51D68-CBDE-439C-AA5B-6284853AD450 wds:Q61757263-37AAED4A-9D4E-4305-A342-574F19289105 wds:Q61757263-4ECCEBDE-6943-47D2-8E01-15C64324F124 wds:Q61757263-6632E841-808E-4C5A-A366-3351B008FC6C wds:Q61757263-CC14852A-4A1A-4706-8EA6-384F3C709DBF wds:Q61757263-D30FD925-14A4-4797-9DC9-090779E5E82B wds:Q61757263-D87886FE-EBA1-4CFC-BF31-0D232E4A136A wds:Q61757263-DFC4380C-0D12-4CC7-9925-62FD27998A2B wds:Q61757263-F2063BEB-F410-447F-865D-92C9C9BEE03B wds:Q61757263-F22F4BAA-DF2F-46C3-BB1F-4C264F048AA8 wds:Q61757263-FB992935-1C6A-421C-9A9E-04C279D074BB
author name string	J Nielsen J Christiansen C Kittas E Dimitriadis N Pandis N Agnantis F C Nielsen P Ioannidis C M Tsiapalis T Trangas I Kyriazoglou
rdfs:label	C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors (en) C‐MYC and IGF‐II mRNA‐binding protein (nl)
skos:prefLabel	C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors (en) C‐MYC and IGF‐II mRNA‐binding protein (nl)
name	C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors (en) C‐MYC and IGF‐II mRNA‐binding protein (nl)
author	wds:Q61757263-EB0E5208-0F25-496D-9617-E70E595DDBEF
author	Martina Samiotaki
title	wds:Q61757263-9129B3EB-EDE4-478B-9D67-A0AA30AC840E
title	C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors (en)
page(s)	wds:Q61757263-6BA7BAE3-DCEF-4F43-8280-042A938413DC
page(s)	480-484
instance of	wds:Q61757263-ED43A33C-654F-4844-9E8D-5677DF8907A3
instance of	scholarly article
PubMed ID	wds:Q61757263-95524F80-A964-4A00-A0ED-7EE6F011158B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11745432
PubMed ID	11745432
published in	wds:Q61757263-91A854D3-6C62-4304-9084-E852A5483BC5
published in	International Journal of Cancer
issue	wds:Q61757263-B54A7A72-0A9D-4FD6-8FA4-3D175192FF72
volume	wds:Q61757263-793ECDBA-E334-43D1-951E-624535291DCB
issue	4
volume	94
DOI	wds:Q61757263-5FAEB1FF-9C2E-4478-A49A-6A3349A53F8C
DOI	http://dx.doi.org/10.1002/IJC.1512
DOI	10.1002/IJC.1512
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61757263
is cites work of	IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2 Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice The RNA-binding protein Vg1 RBP is required for cell migration during early neural development RNA-binding IMPs promote cell adhesion and invadopodia formation Transcriptional Regulation of CRD-BP by c-myc: Implications for c-myc Functions Overexpression of mRNA-binding protein CRD-BP in malignant melanomas Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line Feedback regulation between zipcode binding protein 1 and beta-catenin mRNAs in breast cancer cells Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma Autoantibodies to tumor-associated antigens: reporters from the immune system Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling Role of the RNA-binding protein IMP-2 in muscle cell motility Role of CRD-BP in the growth of human basal cell carcinoma cells Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo Blocking beta-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. p62 Expression in primary carcinomas of the digestive system Relative paradigms between autoantibodies in lupus and autoantibodies in cancer IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1. SRC increases MYC mRNA expression in ER+ breast cancer via mRNA stabilization and inhibition of p53 function. Allele-specific transcriptional elongation regulates monoallelic expression of the IGF2BP1 gene IMP regulates Kuzbanian to control the timing of Notch signalling in follicle cells IMP1, an mRNA binding protein that reduces the metastatic potential of breast cancer in a mouse model A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation Developmental and regional expression and localization of mRNAs encoding proteins involved in RNA translocation IGF2BP1: a novel binding protein of p38 MAPK. Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma. IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer
is cites work of	wds:Q34687371-C250FB75-9900-4D23-A3F3-A64564A6FB12 wds:Q47230860-2D4BC601-D6C9-4178-85DA-D09BE2E1F22F wds:Q49027667-197D9A57-A342-4651-BDA0-8046E2B462D8 wds:Q24567609-5234C481-8C00-4A72-8742-DE39C010845D wds:Q37118192-5A96D786-EF39-4EAF-B8F5-7A47254E5E91 wds:Q36845978-E05A50A6-417C-44E3-BF9E-5582AEEBE75D wds:Q37198930-96624CA0-339B-4DCF-86BE-A9FFD1EDFCCA wds:Q38790090-083B8B7B-9377-4214-91E4-42B2936AB2F6 wds:Q40124454-B40A06D1-8D80-46AC-A115-386B910C4854 wds:Q39804536-60A951D9-C544-46F9-BEC8-0FC49E9D18DA

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software